1. IMMUNITY & PRINCIPLES OF VACCINATION A Presentation by M. Isaac Umapathy, Department of Microbiology & Parasitology, Faculty of Medicine, International Medical & Technological University, Dar-Es-Salaam, Tanzania.
49. Passive Immunization Acute thrombocytopenia and neutropenia Pooled human ig Some autoimmune disease Post-bite Horse Snakebite Prophylaxis Immune human Measles Prophylaxis Pooled human Ig Hepatitis A Post-exposure prophylaxis Immune human Hepatitis B Post exposure (plus vaccine) Immune human Rabies Post-exposure in immunodeficiency Immune human Varicella-Zoster Post-exposure Horse Botulism Post-exposure Horse Gas gangrene Post-exposure Horse Diptheria Post exposure (plus vaccine) Immune human; horse Tetanus Indications Source of Antiserum Infection
50.
51.
52.
53. Antigen Preparations Used in Vaccines Typhoid (New) Subcellular fragment Diphtheria Inactivated toxin (toxoid) Tetanus Cholera (New) Meningococcus Capsular polysaccharide Pneumococcus Haemophilus Hepatitis B Surface antigen Cholera Influenza Typhoid Poli (Salk) Pertussis Rabies Whole killed oranism Varicella-Zoster Yellow fever Polio (Sabin) Rubella Typhoid (New) Mumps BCG Measles Living attenuated organism Vaccinia (Cowpox) Normal heterologous organism Examples Viruses Bacteria Type of antigen
54.
55. Experimental Adjuvants Currently Undergoing Assessment Experimental only Cytokines: IL-1, IL-2, IFN γ . Slow-release devices, Freunds adjuvant. Immune complexes. Experimental, but likely to be approved Liposomes (small synthetic lipid vesicles). Muramyl dipeptide, an active component of Mycobacterial cell walls. Immune stimulating complexes ( ISCOMS) (e.g. from cholesterol or phospholipids). Bacterial toxins (E. coli, pertussis, cholera).